InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (12 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
12
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Serber Zachariah, Directeur Scientifique. Insider active across 1 company, notably Zymergen Inc.. In total, 14 reports have been published. Split: 0 buy · 12 sells. Total volume traded: €223k. Activity tracked since 24 January 2022. The latest transaction was filed on 2 September 2022 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Serber Zachariah
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
2,551,685 sharesCommon StockSEC:0001645842-22-000130:0
3,268 shares@ US$2.212.0% of flowCommon StockSEC:0001645842-22-000122:0
5,435 shares@ US$3.915.7% of flowCommon StockSEC:0001645842-22-000118:0
2,966 shares@ US$2.61252.1% of flowCommon StockSEC:0001645842-22-000109:0
2,797 shares@ US$1.32231.0% of flowCommon StockSEC:0001645842-22-000104:0
2,812 shares@ US$1.67761.4% of flowCommon StockSEC:0001645842-22-000098:0
3,082 shares@ US$1.79031.6% of flowCommon StockSEC:0001645842-22-000063:0
208,000 shares0Common StockSEC:0001645842-22-000034:0
4,011 shares@ US$3.91134.4% of flowCommon StockSEC:0001645842-22-000023:0
1,424 shares@ US$3.911.5% of flowCommon StockSEC:0001645842-22-000021:0
5,435 shares@ US$3.99816.0% of flowCommon StockSEC:0001645842-22-000017:0
5,435 shares@ US$4.32916.4% of flowCommon StockSEC:0001645842-22-000015:0
5,435 shares@ US$5.03397.7% of flowCommon StockSEC:0001645842-22-000011:0
21,730 shares@ US$4.760528.5% of flowCommon StockSEC:0001645842-22-000009:0
14 of 14 declarations
About Serber Zachariah
Zachariah Serber is the Chief Science Officer at Zymergen Inc. In this role, he oversees the company's research and development initiatives, which focus on innovation in biotechnology. With expertise in the sciences, he plays a crucial role in the research strategy of Zymergen Inc.
